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CASE REPORT
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Acute localized exanthematous pustulosis (ALEP) is a 
localized variant of acute generalized exanthematous 
pustulosis, which is characterized by the eruption of multiple 
scattered pustules following drug administration. A 26- 
year-old woman presented with multiple erythematous 
pustules on her face, which had appeared three days after 
taking antibiotics. Histopathological findings showed sub-
corneal pustules and mixed inflammatory cell infiltration in 
the dermis. The pustules were resolved within 2 weeks after 
the patient discontinued the antibiotics. Herein, we present 
a case of a woman with a cutaneous drug reaction consistent 
with ALEP that occurred subsequent to administration of 
antibiotics. (Ann Dermatol 23(S3) S368∼S370, 2011)
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INTRODUCTION
Acute generalized exanthematous pustulosis (AGEP) is a 
severe drug reaction that is characterized by the eruption 
of dozens to hundreds of scattered pustules following drug 
administration
1. A localized variant of this pustular reac-
tion called “acute localized exanthematous pustulosis (AL-
EP)” rarely occurs. 
Herein, we present a case of a woman with a cutaneous 
drug reaction consistent with ALEP that occurred sub-
sequent to administration of antibiotics.
CASE REPORT
A 26-year-old woman presented with an acute outbreak of 
asymptomatic multiple pustules and surrounding ery-
thema affecting the face. One week ago, she took anti-
biotics (cephalosporine, bactrim, and vancomycin) for the 
treatment of otitis media. After three days, she reported 
subjective fever, fatigue and a chilling sensation and pus-
tules with surrounding erythema were observed on her 
face. The pustules were superficial and nonfollicular with 
a surrounding erythema. Her white cell count was 1.77× 
10
9 L
-1, with an increased neutrophil count (80.4%). The 
erythrocyte sedimentation rate (ESR) and c-reactive protein 
(CRP) were elevated (ESR: 55 mm, CRP: 43.91 mg/dl). The 
blood chemistry, liver function, and renal function tests 
were within the normal limit. Cultures were negative for 
bacteria. Histopathological findings showed subcorneal 
pustules with scattered apoptotic keratinocytes adjacent to 
the pustules. The papillary dermis was edematous and 
prominent mixed inflammatory cells infiltrated in the 
dermis, with leukocytoclastic vasculitis. She was disconti-
nued use of the antibiotics and was treated with systemic 
corticosteroid (methylprednisolone 8 mg/day). The pus-
tules were rapidly resolved over several days. Two weeks 
later, most lesions disappeared and small hemorrhagic 
crusts and pigmentation remained. The scheduled patch 




AGEP is an uncommon but well-known cutaneous drug 
reaction that is characterized by the eruption of dozens to 
hundreds of scattered pustules following drug admi-Acute Localized Exanthematous Pustulosis on the Face
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nistration. The pustules are acute, generalized, nonfol-
licular and often coalesce on an edematous, erythematous 
background. The eruption can be accompanied by fever 
and neutrophilic leukocytosis
1. Antibiotics are the most 
commonly drugs that causes these symptoms although 
non-steroidal anti-inflammatory drugs, antifungals, calci-
um antagonists, and antiulcer drugs may also trigger this 
response
2. The pathophysiological mechanism of these 
symptoms remains largely unknown. But previous studies 
in patients with AGEP have revealed a high rate of 
positive patch test responses and in vitro lymphocyte 
proliferative responses compared with other drug erup-
tion. This strongly suggests that this adverse cutaneous 
reaction occurs by a drug-specific T-cell-mediated pro-
cess
3. These specific T-cells produce large amounts of 
cytokines, which contribute to the accumulation of neu-
trophils
4.
ALEP is a less common form of pustular drug eruption, in 
which lesions are consistent with the characteristics of 
AGEP but are typically localized to the face, neck or chest. 
Prange
5 and colleagues first defined ALEP in 2005. They 
described a woman whose symptoms fit the criteria of 
AGEP but whose lesions were localized to the face. They 
suggested that ALEP was a variant of AGEP both clinically 
and histopathologically. To the best of our knowledge, 
only nine separate case of this variant has been reported. 
Two cases occurred following administration of amoxi-
cillin-clavulanic acid
5,6, four following administration of 
amoxicillin only
6-9, and one after administration of levo-
floxacin
10. Other causative drugs aside from antibiotics 
include ibuprofen
3 and paracentamol in pregnant wo-
man
11. In reported cases, the lesions are consistent with 
the characteristics of AGEP but are localized typically to 
the face, neck, and chest. 
In the present case, the Sweet syndrome (acute febrile 
neutrophilic dermatosis) should be differentiated. Typical 
findings of the Sweet syndrome include the sudden 
appearance of a fever, increased neutrophilic count, ery-
thematous papules, pustules on the head, neck, and 
extremities and infiltration of neutrophils throughout the 
dermis. However, in the Sweet syndrome, the lesions are 
usually tender and there is no evidence of leukocytoclastic 
vasculitis in the dermis
12. Histologically, the subcorneal 
pustules of ALEP resembled those of pustular psoriasis or 
subcorneal pustulosis. Recent drug administration history, 
no personal history of psoriasis, more acute course and 
rapid spontaneous healing allowed us to differentiate the 
diagnosis from other pustular dermatoses
13. 
The most important aspect of treatment is the immediate 
withdrawal of the suspected agent and supportive therapy. 
Other specific treatments are not usually needed, because 
ALEP is a self-limited disease with a favorable prognosis in 
most cases
3. However, topical or systemic corticosteroids 
can be helpful because of their anti-inflammatory pro-
perties
14. 
In our case, the lesions developed rapidly after admi-
nistration of antibiotics and were resolved within several 
days of discontinuing the treatment. Based on this his-
tologic findin, the symptoms appeared to correspond to 
AGEP, which results in unusual characteristics that are 
limited on the face. All antibiotics that had been used in 
this case can lead AGEP. However, only two cases at-
tributed to vancomycin have been reported
15. Cephal-
osporins are relatively common causative drugs for AGEP, 
but interestingly not sulfonamides, who have a high 
potential of causing other drug eruptions
1. Therefore, we 
assumed that cephalosporins were the causative drug in 
this case. 
Herein, we present a case of a woman with a cutaneous 
drug reaction consistent with ALEP that occurred sub-
sequent to administration of antibiotics. Further study may 
be required to facilitate the correct diagnosis and treat-
ment for this rare disorder. 
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